Lab Information

Bertrand Lebouché (MD/PhD)

Scientist
Centre for Outcomes Research and Evaluation
Department of Family Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 60%
 Epidemiology: 0%
 Evaluation: 40%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

HIV • adherence • antiretroviral therapy • patient engagement • patient-reported outcome measures • mHealth • HCV • men who have sex with men • HIV prevention

Research Interests

My research interests are especially centred on innovating HIV care through stakeholder engagement and the use of patient-centred mobile health technologies. I am currently developing a new patient-reported outcome measure for electronic administration during routine HIV care focused on patient-identified barriers to adhering to antiretroviral therapy. In partnership with developers of the Opal patient portal, I am adapting Opal for use in both HIV and COVID-19 follow-up. Furthermore, with a team from the Polytechnique de Montréal, I am creating a chatbot to conversationally help answer pragmatic questions people living with HIV may have about their antiretroviral therapy. The patient experience of HIV care is also a prominent theme of my research, including among HIV-positive newcomers to Quebec. My research program is affiliated with my CIHR Strategy for Patient-Oriented Research (SPOR) Mentorship Chair, which enables trainees to gain experience with stakeholder engagement in research.


Team Members

Name Position

Latest Publications

  1. Ma, Y., Lessard, D., Vicente, S., Engler, K., Rodriguez Cruz, A., Laymouna, M., Opal-COVID Patient Expert Committee, Hijal, T., Del Balso, L., Thériault, G., Paisible, N., Kronfli, N., Pomey, M.-P., Peiris, H., Barkati, S., Brouillette, M.-J., Klein, M., Cox, J., de Pokomandy, A., Asselah, J., Bartlett, S. J. & Lebouché, B. (2024). Implementing a Patient Portal for the Remote Follow-Up of Self-Isolating Patients With COVID-19 Infection Through Patient and Stakeholder Engagement (the Opal-COVID Study): Mixed Methods Pilot Study. Journal of participatory medicine, vol. 16, p. e48194.
  2. Kronfli, N., Mambro, A., Riback, L. R., Ortiz-Paredes, D., Dussault, C., Chalifoux, S., Del Balso, L., Petropoulos, A., Lim, M., Halavrezos, A., Sebastiani, G., Klein, M. B., Lebouche, B., Cox, J. & Akiyama, M. J. (2024). Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada. The International journal on drug policy, vol. 133, p. 104624.
  3. Kudrina, I., Page, M. G., Choinière, M., Shir, Y., Eisenberg, M. J., Ben-Sasson, M., Lebouché, B. & Puzhko, S. (2024). Risk of infections among persons treated with opioids for chronic pain: a systematic review and meta-analysis protocol. BMJ open, vol. 14, p. e083791.
  4. Attieh, R., Pomey, M.-P., Lebouché, B., Ma, Y., Hijal, T. & Poder, T. G. (2024). Cost Analysis of a Patient Portal Used to Remotely Monitor COVID-19 Patients in Quebec. Journal of primary care & community health, vol. 15, p. 21501319241271190.
  5. Ma, Y., Achiche, S., Tu, G., Vicente, S., Lessard, D., Engler, K., Lemire, B., MARVIN chatbots Patient Expert Committee, Laymouna, M., de Pokomandy, A., Cox, J. & Lebouché, B. (2024). The first AI-based Chatbot to promote HIV self-management: A mixed methods usability study. HIV medicine.
  6. Wang, Z., Zhao, X., Shen, H., Wang, H., Cheng, G., Gao, Y. N., Zuo, W., Xu, Z., Avallone, F., Arora, A. K., Guo, M., Simmons, R., Lessard, D., Beesley, T., Zheng, J. C., Lebouché, B. & Bergman, H. (2024). Evaluation of the McGill-Tongji Blended Education Program for Teacher Leaders in General Practice: The importance of partnership and contextualization in International Primary Care Training Initiatives. Health care science, vol. 3, p. 238-248.
  7. Brenner, B. G., Ibanescu, R.-I., Oliveira, M., Margaillan, G., Lebouché, B., Thomas, R., Baril, J. G., Lorgeoux, R.-P., Roger, M., Routy, J.-P. & (2024). Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022. Viruses, vol. 16.
  8. Laymouna, M., Ma, Y., Lessard, D., Engler, K., Therrien, R., Schuster, T., Vicente, S., Achiche, S., El Haj, M. N., Lemire, B., Kawaiah, A. & Lebouché, B. (2024). Needs-Assessment for an Artificial Intelligence-Based Chatbot for Pharmacists in HIV Care: Results from a Knowledge-Attitudes-Practices Survey. Healthcare (Basel, Switzerland), vol. 12.
  9. Kablawi, D., Milic, J., Thomas, T., Fotsing Tadjo, T., Cinque, F., Elgretli, W., Gioè, C., Lebouché, B., Tsochatzis, E., Finkel, J., Bhagani, S., Cascio, A., Guaraldi, G., Mazzola, G., Saeed, S. & Sebastiani, G. (2024). Metabolic dysfunction-associated steatohepatitis exhibits sex differences in people with HIV. HIV medicine, vol. 25, p. 1259-1269.
  10. Mboumba Bouassa, R.-S., Needham, J., Nohynek, D., Samarani, S., Bobeuf, F., Del Balso, L., Paisible, N., Vertzagias, C., Sebastiani, G., Margolese, S., Mandarino, E., Singer, J., Klein, M., Lebouché, B., Cox, J., Vulesevic, B., Müller, A., Lau, E., Routy, J.-P., Jenabian, M.-A. & Costiniuk, C. T. (2024). Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028. Journal of personalized medicine, vol. 14.
More on PubMed 



See also

Card image
Joseph
Cox


See profile
Card image
Jean-Pierre
Routy


See profile
Card image
Marina
Klein


See profile
Card image
Nadine
Kronfli


See profile
Card image
Giada
Sebastiani


See profile
Card image
Cecilia
Costiniuk


See profile